PIWIL1 and cancer: Regarding the PAM50 subtype, patients with low PIWI-like-2-expressing cancer suffered about five times more often from basal-like (34.5%) and half as often from the Luminal A subtype (30.9%) compared to a high PIWI-like 2 expression (7.1% and 68.8%, respectively).